BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10413211)

  • 1. CD4 TCRBV CDR3 analysis in prevalent SLE cases from two ethnic groups.
    Fraser PA; Lu LY; DeCeulaer K; Schur PH; Fici D; Awdeh Z; Ding WZ; Levitan E; Lew R; Uko G; Gonzalez C
    Lupus; 1999; 8(4):311-9. PubMed ID: 10413211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    Kim K; Bang SY; Yoo DH; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Kang YM; Suh CH; Shim SC; Lee SS; Lee J; Chung WT; Kim SK; Choe JY; Nath SK; Lee HS; Bae SC
    PLoS One; 2016; 11(2):e0150283. PubMed ID: 26919467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.
    Smikle M; Christian N; DeCeulaer K; Barton E; Roye-Green K; Dowe G; Anderson N; Nicholson G
    South Med J; 2002 Jul; 95(7):717-9. PubMed ID: 12144077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.
    Christian N; Smikle MF; DeCeulaer K; Daniels L; Walravens MJ; Barton EN
    West Indian Med J; 2007 Mar; 56(2):130-3. PubMed ID: 17910142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis peptide E7/HLA-DRB1 tetramers with different HLA-DR alleles bound CD4
    Gan Y; Wang C; Fang Y; Yao Y; Tu X; Wang J; Huang X; Tan Y; Chen T; Zhang K; Shen Y; Zhou L; Liu J; Lai X
    Sci Rep; 2018 Jul; 8(1):9903. PubMed ID: 29967390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone-Specific CD4
    Ramirez GA; Tassi E; Noviello M; Mazzi BA; Moroni L; Citterio L; Zagato L; Tombetti E; Doglio M; Baldissera EM; Bozzolo EP; Bonini C; Dagna L; Manfredi AA
    Arthritis Rheumatol; 2024 May; 76(5):739-750. PubMed ID: 38111123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections.
    Roglic M; Macphee RD; Duncan SR; Sattler FR; Theofilopoulos AN
    Clin Exp Immunol; 1997 Jan; 107(1):21-30. PubMed ID: 9010252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.
    Zhao LP; Alshiekh S; Zhao M; Carlsson A; Larsson HE; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Persson M; Samuelsson U; Örtqvist E; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å;
    Diabetes; 2016 Mar; 65(3):710-8. PubMed ID: 26740600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus.
    Lande R; Pietraforte I; Mennella A; Palazzo R; Spinelli FR; Giannakakis K; Spadaro F; Falchi M; Riccieri V; Stefanantoni K; Conrad C; Alessandri C; Conti F; Frasca L
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Ohnogi Y; Hong GH; Kuwata S; Takeuchi F
    Int J Immunogenet; 2013 Apr; 40(2):126-30. PubMed ID: 22862923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing.
    Ozaki Y; Suzuki S; Shigenari A; Okudaira Y; Kikkawa E; Oka A; Ota M; Mitsunaga S; Kulski JK; Inoko H; Shiina T
    Tissue Antigens; 2014 Jan; 83(1):10-6. PubMed ID: 24355003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus.
    Suggs MJ; Majithia V; Lewis RE; Cruse JM
    Exp Mol Pathol; 2011 Oct; 91(2):548-62. PubMed ID: 21497601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II antigens associated with systemic lupus erythematosus in black South Africans.
    Rudwaleit M; Tikly M; Gibson K; Pile K; Wordsworth P
    Ann Rheum Dis; 1995 Aug; 54(8):678-80. PubMed ID: 7677446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis.
    Grunewald J; Halapi E; Wahlström J; Giscombe R; Nityanand S; Sanjeevi C; Lefvert AK
    Blood; 1998 Nov; 92(10):3737-44. PubMed ID: 9808568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan.
    Lu LY; Ding WZ; Fici D; Deulofeut R; Cheng HH; Cheu CC; Sung PK; Schur PH; Fraser PA
    Arthritis Rheum; 1997 Jun; 40(6):1138-45. PubMed ID: 9182925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.
    Texier C; Pouvelle-Moratille S; Busson M; Charron D; Ménez A; Maillère B
    Eur J Immunol; 2001 Jun; 31(6):1837-46. PubMed ID: 11433380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
    Zhu X; Zhu P; Guo XL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
    Skarsvåg S; Hansen KE; Holst A; Moen T
    Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1,3,4,5 and -DQB1 allele frequencies and HLA-DR/DQ linkage disequilibrium of 231 German caucasoid patients and their corresponding 821 potential unrelated stem cell transplants.
    Knipper AJ; Hakenberg P; Enczmann J; Kuhröber A; Kiesel U; Kögler G; Wernet P
    Hum Immunol; 2000 Jun; 61(6):605-14. PubMed ID: 10825589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.
    Rezvany MR; Jeddi-Tehrani M; Osterborg A; Kimby E; Wigzell H; Mellstedt H
    Blood; 1999 Aug; 94(3):1063-9. PubMed ID: 10419899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.